Visceral obesity in Asian living kidney donors significantly impacts early renal function after donor nephrectomy.


Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 20 06 2018
accepted: 12 11 2018
pubmed: 21 11 2018
medline: 20 2 2020
entrez: 21 11 2018
Statut: ppublish

Résumé

Obesity may be a risk factor for kidney donors to develop reduced renal function. The Framingham heart study suggested that visceral adipose tissue (VAT) confers a more adverse metabolic profile compared with subcutaneous adipose tissue (SAT). Asians tend to have a higher VAT composition and it is unclear if their kidney function is affected differently. We hypothesized that Asian living kidney donors who have visceral obesity are at a higher risk of renal function deterioration 1 year after donation. Between 2011 and 2014, we retrospectively evaluated data from 73 consecutive patients (52% male; mean age 44.9 ± 11.7 years) before they underwent donor nephrectomy and at their 1 year routine follow-up. VAT and SAT were measured at the level of the umbilicus on pre-operative computerized tomography (CT). Visceral obesity (VO) was defined as a VAT > 100 cm [2] and patients were then further divided and compared in two subgroups: VAT > 100 and < 100 cm [2]. Estimated glomerular filtration rate (eGFR, mL/min per 1.73 m [2]) was calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation pre-operatively and 1 year post-operatively. Both subgroups had similar baseline kidney function (P = NS) pre-operatively. At the 1 year follow-up, patients with VO experienced a more significant decline of renal function (109 ± 9 to 89 ± 8 mL/min per 1.73 m Visceral obesity as defined by VAT > 100 cm

Identifiants

pubmed: 30456710
doi: 10.1007/s00345-018-2566-2
pii: 10.1007/s00345-018-2566-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2231-2236

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

Am J Kidney Dis. 2012 Sep;60(3):500-2
pubmed: 22721932
JAMA. 2003 Jan 1;289(1):76-9
pubmed: 12503980
Kidney Int. 2014 Jul;86(1):162-7
pubmed: 24284516
J Atheroscler Thromb. 2012;19(11):1006-18
pubmed: 22785136
Lancet. 2003 Jun 14;361(9374):2032-5
pubmed: 12814714
Ann Intern Med. 1985 Dec;103(6 ( Pt 2)):1073-77
pubmed: 4062128
Nat Med. 1996 Jul;2(7):800-3
pubmed: 8673927
Ann Med. 2012 Feb;44(1):82-92
pubmed: 20964583
Am J Clin Nutr. 2007 Aug;86(2):353-9
pubmed: 17684205
Br J Surg. 2005 Oct;92(10):1261-2
pubmed: 16078294
J Urol. 2013 Nov;190(5):1820-6
pubmed: 23770137
N Engl J Med. 2005 Apr 21;352(16):1685-95
pubmed: 15843671
Am J Transplant. 2017 Apr;17(4):893-900
pubmed: 27529688
Ann N Y Acad Sci. 2013 Apr;1281:64-91
pubmed: 23551121
J Clin Invest. 2003 Dec;112(12):1796-808
pubmed: 14679176
Intern Med. 2011;50(16):1643-8
pubmed: 21841320
Nature. 2006 Dec 14;444(7121):860-7
pubmed: 17167474
Ann Acad Med Singap. 2004 May;33(3):294-7
pubmed: 15175766
Am J Clin Nutr. 1987 Jan;45(1):7-13
pubmed: 3799506
Surg Endosc. 2009 Sep;23(9):2085-93
pubmed: 19116746
Radiology. 1999 Apr;211(1):283-6
pubmed: 10189485
Transplant Proc. 2014;46(2):310-3
pubmed: 24655950
PLoS One. 2015 Jun 17;10(6):e0131119
pubmed: 26083499
JAMA. 2014 Feb 12;311(6):579-86
pubmed: 24519297
Surg Obes Relat Dis. 2016 Mar-Apr;12(3):600-605
pubmed: 26522229
J Clin Invest. 1995 May;95(5):2409-15
pubmed: 7738205
Prim Care. 2003 Jun;30(2):281-99, v-vi
pubmed: 14567148
Atherosclerosis. 1994 Jun;107(2):239-46
pubmed: 7980698
Circ J. 2004 Nov;68(11):975-81
pubmed: 15502375
Int J Obes Relat Metab Disord. 2002 Mar;26(3):398-402
pubmed: 11896496
Transplantation. 2005 Mar 27;79(6 Suppl):S53-66
pubmed: 15785361
J Clin Endocrinol Metab. 2001 May;86(5):1930-5
pubmed: 11344187
Nutr Metab (Lond). 2011 Aug 16;8:57
pubmed: 21846385
Circulation. 2007 Jul 3;116(1):39-48
pubmed: 17576866
Circ J. 2002 Nov;66(11):987-92
pubmed: 12419927
Obes Rev. 2002 Aug;3(3):141-6
pubmed: 12164465

Auteurs

Gregory Xiang Wen Pek (GXW)

National University Centre for Organ Transplantation, National University Hospital, Singapore, Singapore.

Clara Lee Ying Ngoh (CLY)

National University Centre for Organ Transplantation, National University Hospital, Singapore, Singapore.

Boon Wee Teo (BW)

National University Centre for Organ Transplantation, National University Hospital, Singapore, Singapore.

Anantharaman Vathsala (A)

National University Centre for Organ Transplantation, National University Hospital, Singapore, Singapore.

Benjamin Yen Seow Goh (BYS)

National University Centre for Organ Transplantation, National University Hospital, Singapore, Singapore.

Clement Hsiang Rong Yong (CHR)

National University Centre for Organ Transplantation, National University Hospital, Singapore, Singapore.

Lata Raman (L)

National University Centre for Organ Transplantation, National University Hospital, Singapore, Singapore.

Ho Yee Tiong (HY)

National University Centre for Organ Transplantation, National University Hospital, Singapore, Singapore. surthy@nus.edu.sg.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH